Indication

Soft or connective tissue sarcoma

Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures. Read more about Soft or connective tissue sarcoma

38 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Soft or connective tissue sarcoma therapies.

Showing 1–9 of 38 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Parke-Davis Pfizer

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
SUN PHARMACEUTI

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Laboratories Div
Filter & compare in the drug finder →Opens the drug finder with Soft or connective tissue sarcoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Soft or connective tissue sarcoma.

Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures.

These neoplasms can develop in individuals of any age and occur throughout the body, most commonly involving the extremities, retroperitoneum, trunk, and head and neck.

Pathophysiologically, they originate from mesenchymal progenitor cells and are characterized by expansive local growth—often forming a false fibrous capsule with microscopic infiltrative extensions—alongside a tendency for local recurrence and hematogenous dissemination, predominantly to the lungs.

Clinically, they typically present as painless, progressively enlarging soft-tissue masses, though retroperitoneal or deep visceral lesions may remain clinically silent until they cause compression of adjacent structures.

Personalize your experience

Follow Soft or connective tissue sarcoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it